A technical advisory group of the WHO reviewing data on Covaxin for the emergency use listing of India's vaccine and if it is satisfied a recommendation is expected within the next 24 hours or so
India's Covid-19 vaccination coverage has crossed 103 crore with over 51 lakh vaccine doses administered on Tuesday, the Union health ministry said
Delhi reported 41 fresh Covid-19 cases at a positivity rate of 0.08 per cent while there was no fatality due to the infection, according to data shared by the health department
The Centre has asked the state government to immediately undertake a review of cases and deaths, and stressed on the importance of ensuring Covid-safe festivities.
Mumbai reported 293 new coronavirus infections on Tuesday, an uptick from a day ago, and five fresh fatalities, taking the tally of Covid-19 cases to 7,54,249 and the death toll to 16,225
As many as 79,122 samples were tested in the last 24 hours.
The RNA-based vaccine, meant for the age group of 12 to 18 besides adults, got the Emergency Use Authorisation from the drug regulator on August 20.
The Centre on Saturday asked the States and Union Territories (UTs) to speed up the vaccination programme with focus on second Covid doses across the country
Millions of Indians have taken the shot produced by Bharat Biotech but many have been unable to travel pending the WHO approval
Higher transmission rates were associated with lower temperatures and humidity, the report said.
Digital technologies are transforming all areas of life and health, a trend that has been accelerated by the Covid-19 pandemic, but the benefits of these advances are not reaching everyone equally.
Second dose vaccinations are picking up pace, as the ratio of those turning up for the second dose is increasing
India saw a single-day rise of 12,428, while the active cases declined to 163,816
On October 14, Biological E said that it would submit final data on COVID-19 vaccine Corbevax till November end, informed Government sources.
The lockdown comes a day after a warning from National Health Commission officials that the outbreak would continue to worsen after spreading to 11 provinces in about a week
Health officials are aiming to get immunizations to younger children before the holiday season, when travel and indoor activity can bring an increased risk of infection
The US will lift all travel restrictions for incoming non-citizen, non-immigrant travellers from November 8, with only limited exceptions
These include glimepiride tablet of strength 1 mg, with ceiling price at Rs 3.6 per tablet, while that for 2 mg is Rs 5.72 per tablet
Apollo Hospitals, in a statement, said, however, it is an "indicative list" and the "final list of co-morbidities eligible for free vaccination would be as per the list published by the government"
The booster dose consists of half the dose normally given to adults